PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
60.29
Similar ESG score to KOD's 60.45. Bruce Berkowitz would investigate if industry ESG norms adequately address regulatory risks.
50.00
Environmental score 80-90% of KOD's 58.62. Walter Schloss would scrutinize carbon exposure and transition planning.
62.54
Similar social score to KOD's 60.23. Bruce Berkowitz would investigate if industry social norms adequately address stakeholder expectations.
68.32
Governance score 1.1-1.2x KOD's 62.50. Guy Spier would verify if superior governance translates to better capital allocation and strategic execution.